BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totaling 32,798 shares, a decline of 60.9% from the September 15th total of 83,940 shares. Based on an average trading volume of 128,882 shares, the days-to-cover ratio is currently 0.3 days.
Institutional Trading of BlackRock Health Sciences Term Trust
A number of large investors have recently added to or reduced their stakes in BMEZ. Saba Capital Management L.P. bought a new stake in BlackRock Health Sciences Term Trust in the 1st quarter valued at $10,907,000. Calamos Advisors LLC bought a new position in BlackRock Health Sciences Term Trust during the first quarter worth $740,000. Corient Private Wealth LP bought a new position in BlackRock Health Sciences Term Trust during the second quarter worth $467,000. Lazard Asset Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 64.2% in the first quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock valued at $8,926,000 after purchasing an additional 243,054 shares during the last quarter. Finally, Rivernorth Capital Management LLC raised its position in shares of BlackRock Health Sciences Term Trust by 24.8% in the first quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock valued at $11,620,000 after purchasing an additional 160,629 shares during the period.
BlackRock Health Sciences Term Trust Stock Down 1.0%
Shares of NYSE:BMEZ traded down $0.17 during trading on Tuesday, hitting $16.25. 49,471 shares of the company were exchanged, compared to its average volume of 201,705. BlackRock Health Sciences Term Trust has a fifty-two week low of $13.70 and a fifty-two week high of $17.25. The firm has a fifty day moving average price of $16.56 and a two-hundred day moving average price of $15.32.
BlackRock Health Sciences Term Trust Announces Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a publicly traded closed-end investment fund managed by BlackRock Advisors, LLC. The fund seeks to provide total returns through a combination of current income and long-term capital appreciation by investing primarily in companies involved in the health sciences sector.
BMEZ’s investment universe includes businesses in areas such as biotechnology, pharmaceuticals, medical devices, health-care services, and life-sciences tools and equipment.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
